| Evaluation of hybrid 68Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy M Eiber, T Maurer, M Souvatzoglou, AJ Beer, A Ruffani, B Haller, ... Journal of nuclear medicine 56 (5), 668-674, 2015 | 1189 | 2015 |
| Imaging biomarker roadmap for cancer studies JPB O'connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ... Nature reviews Clinical oncology 14 (3), 169-186, 2017 | 1061 | 2017 |
| Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients … T Maurer, JE Gschwend, I Rauscher, M Souvatzoglou, B Haller, G Weirich, ... The Journal of urology 195 (5), 1436-1443, 2016 | 815 | 2016 |
| Noninvasive Visualization of the Activated αvβ3 Integrin in Cancer Patients by Positron Emission Tomography and [18F]Galacto-RGD R Haubner, WA Weber, AJ Beer, E Vabuliene, D Reim, M Sarbia, ... PLoS medicine 2 (3), e70, 2005 | 625 | 2005 |
| Simultaneous 68Ga-PSMA HBED-CC PET/MRI improves the localization of primary prostate cancer M Eiber, G Weirich, K Holzapfel, M Souvatzoglou, B Haller, I Rauscher, ... European urology 70 (5), 829-836, 2016 | 584 | 2016 |
| First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses A Drzezga, M Souvatzoglou, M Eiber, AJ Beer, S Fürst, A Martinez-Möller, ... Journal of Nuclear Medicine 53 (6), 845-855, 2012 | 582 | 2012 |
| Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment HA Wieder, BLDM Brucher, F Zimmermann, K Becker, F Lordick, A Beer, ... Journal of Clinical Oncology 22 (5), 900-908, 2004 | 581 | 2004 |
| Positron Emission Tomography Using [18F]Galacto-RGD Identifies the Level of Integrin αvβ3 Expression in Man AJ Beer, R Haubner, M Sarbia, M Goebel, S Luderschmidt, AL Grosu, ... Clinical Cancer Research 12 (13), 3942-3949, 2006 | 438 | 2006 |
| Spect/ct AK Buck, S Nekolla, S Ziegler, A Beer, BJ Krause, K Herrmann, ... Journal of Nuclear Medicine 49 (8), 1305-1319, 2008 | 429 | 2008 |
| Biodistribution and pharmacokinetics of the αvβ3-selective tracer 18F-galacto-RGD in cancer patients AJ Beer, R Haubner, M Goebel, S Luderschmidt, ME Spilker, HJ Wester, ... Journal of nuclear medicine 46 (8), 1333-1341, 2005 | 353 | 2005 |
| Imaging of integrin αvβ3 expression AJ Beer, M Schwaiger Cancer and metastasis reviews 27, 631-644, 2008 | 283 | 2008 |
| [18F]Galacto-RGD Positron Emission Tomography for Imaging of αvβ3 Expression on the Neovasculature in Patients with Squamous Cell Carcinoma of the Head … AJ Beer, AL Grosu, J Carlsen, A Kolk, M Sarbia, I Stangier, P Watzlowik, ... Clinical Cancer Research 13 (22), 6610-6616, 2007 | 282 | 2007 |
| Radiolabelled RGD peptides for imaging and therapy FC Gaertner, H Kessler, HJ Wester, M Schwaiger, AJ Beer European journal of nuclear medicine and molecular imaging 39, 126-138, 2012 | 256 | 2012 |
| Value of 68Ga-PSMA HBED-CC PET for the assessment of lymph node metastases in prostate cancer patients with biochemical recurrence: comparison with histopathology after salvage … I Rauscher, T Maurer, AJ Beer, FP Graner, B Haller, G Weirich, A Doherty, ... Journal of Nuclear Medicine 57 (11), 1713-1719, 2016 | 255 | 2016 |
| Patterns of αvβ3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET AJ Beer, M Niemeyer, J Carlsen, M Sarbia, J Nährig, P Watzlowik, ... Journal of Nuclear Medicine 49 (2), 255-259, 2008 | 250 | 2008 |
| Imaging of integrin αvβ3 expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography O Schnell, B Krebs, J Carlsen, I Miederer, C Goetz, RH Goldbrunner, ... Neuro-oncology 11 (6), 861-870, 2009 | 249 | 2009 |
| Observation of the swallowing process by application of videofluoroscopy and real-time magnetic resonance imaging—consequences for retronasal aroma stimulation A Buettner, A Beer, C Hannig, M Settles Chemical Senses 26 (9), 1211-1219, 2001 | 247 | 2001 |
| Comparison of integrin αvβ3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG AJ Beer, S Lorenzen, S Metz, K Herrmann, P Watzlowik, HJ Wester, ... Journal of Nuclear Medicine 49 (1), 22-29, 2008 | 229 | 2008 |
| Expression of Integrin αvβ3 in Gliomas Correlates with Tumor Grade and Is not Restricted to Tumor Vasculature O Schnell, B Krebs, E Wagner, A Romagna, AJ Beer, SJ Grau, N Thon, ... Brain pathology 18 (3), 378-386, 2008 | 220 | 2008 |
| In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma K Philipp‐Abbrederis, K Herrmann, S Knop, M Schottelius, M Eiber, ... EMBO molecular medicine 7 (4), 477-487, 2015 | 215 | 2015 |
